sdgr-20240331

000149097812-312024Q1falseSubsequent Events

TBD

March 4, 202446800014909782024-01-012024-03-310001490978us-gaap:CommonStockMember2024-04-22xbrli:shares0001490978sdgr:LimitedCommonStockMember2024-04-2200014909782024-03-31iso4217:USD00014909782023-12-31iso4217:USDxbrli:shares0001490978sdgr:UnallocatedCommonStocksMember2023-12-310001490978sdgr:UnallocatedCommonStocksMember2024-03-310001490978sdgr:LimitedCommonStockMember2024-03-310001490978sdgr:LimitedCommonStockMember2023-12-310001490978sdgr:SoftwareProductsAndServicesMember2024-01-012024-03-310001490978sdgr:SoftwareProductsAndServicesMember2023-01-012023-03-310001490978sdgr:DrugDiscoveryMember2024-01-012024-03-310001490978sdgr:DrugDiscoveryMember2023-01-012023-03-3100014909782023-01-012023-03-310001490978us-gaap:CommonStockMember2023-12-310001490978sdgr:LimitedCommonStockMember2023-12-310001490978us-gaap:AdditionalPaidInCapitalMember2023-12-310001490978us-gaap:RetainedEarningsMember2023-12-310001490978us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001490978us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001490978us-gaap:CommonStockMember2024-01-012024-03-310001490978us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001490978us-gaap:RetainedEarningsMember2024-01-012024-03-310001490978us-gaap:CommonStockMember2024-03-310001490978sdgr:LimitedCommonStockMember2024-03-310001490978us-gaap:AdditionalPaidInCapitalMember2024-03-310001490978us-gaap:RetainedEarningsMember2024-03-310001490978us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001490978us-gaap:CommonStockMember2022-12-310001490978sdgr:LimitedCommonStockMember2022-12-310001490978